Your browser doesn't support javascript.
loading
Antifibrotic therapies reduce mortality and hospitalization among Medicare beneficiaries with idiopathic pulmonary fibrosis.
Mooney, Joshua; Reddy, Sheila R; Chang, Eunice; Broder, Michael S; Gokhale, Sohum; Corral, Mitra.
Afiliación
  • Mooney J; Department of Medicine, Stanford University, Stanford, CA.
  • Reddy SR; Partnership for Health Analytics, LLC, Beverly Hills, CA.
  • Chang E; Partnership for Health Analytics, LLC, Beverly Hills, CA.
  • Broder MS; Partnership for Health Analytics, LLC, Beverly Hills, CA.
  • Gokhale S; Partnership for Health Analytics, LLC, Beverly Hills, CA.
  • Corral M; Genentech, Inc., South San Francisco, CA.
J Manag Care Spec Pharm ; 27(12): 1724-1733, 2021 12.
Article en En | MEDLINE | ID: mdl-34818092
Asunto(s)
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Mortalidad / Medicare / Fibrosis Pulmonar Idiopática / Antifibróticos / Hospitalización Tipo de estudio: Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Aged / Aged80 / Female / Humans / Male País/Región como asunto: America do norte Idioma: En Año: 2021 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Mortalidad / Medicare / Fibrosis Pulmonar Idiopática / Antifibróticos / Hospitalización Tipo de estudio: Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Aged / Aged80 / Female / Humans / Male País/Región como asunto: America do norte Idioma: En Año: 2021 Tipo del documento: Article